Acute Porphyria Drug Database

Monograph

S01BA02 - Hydrocortisone
Not porphyrinogenic
NP

Rationale
Probably insignificant systemic exposure. Substrate for CYPs 3A4, 3A7, 11 B2. Inducer and inhibitor (!) of CYP 3A4. Several references stating non-porphyrinogenicity.
Chemical description
Glucocorticoid for eye application. Glucocorticoid: South African list: use French list: authorized EPI-list: safe Merck Index: safe Kalman, Bonkowski: safe

Similar drugs
Explore alternative drugs in similar therapeutic classes S01B / S01BA or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Softacor · Softacor 3,35 mg/ml oogdruppels, oplossing in verpakking voor eenmalig gebruik
Belgium
Softacor · Softacor 3.35 mg/ml collyre sol. récip. unidose
United Kingdom
Hydrocortisone · Hydrocortisone 0.5% eye ointment · Hydrocortisone 1% eye ointment · Hydrocortisone 2.5% eye ointment · Hydrocortisone acetate · Hydrocortisone acetate 1% eye drops · Softacort · Softacort 3.35mg/ml eye drops 0.4ml unit dose
Denmark
Softacort
Norway
Softacort
Poland
Softacort
Luxembourg
Softacor
Iceland
Softacort
Finland
Softacort
Latvia
Hydrocortisonum · Hydrocortisonum PharmaSwiss
Serbia
Hydrocortison · Hydrocortison Galenika · Softacort · Softacort®
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙